Low testosterone
Low testosterone is a clinical syndrome in men, not just a lab value, and it generally requires persistent symptoms plus a total testosterone below 350 ng/dL or a free testosterone below 100 pg/mL on proper morning testing. This hub explains what low testosterone means, why it happens, how to test for it correctly, and how treatment decisions change once LH and FSH are measured. Use the sections below to move from basics to diagnosis, causes, related conditions, and the treatment paths that actually fit the biology.
Start with your question
- I want to understand what low testosterone is and how common it is
- Show me the main causes, including primary, secondary, and functional hypogonadism
- Help me recognize the symptoms that matter most
- Show me how to test correctly and avoid misleading results
- I want to see how low testosterone connects to obesity, diabetes, mood, and bone health
- Help me rule out conditions that can look like low testosterone
- Show me the difference between Enclomiphene and testosterone replacement therapy
- I want to know what recovery, monitoring, and long term management look like
Key takeaways
- Low testosterone is not diagnosed by a number alone. It requires persistent symptoms plus biochemical evidence of testosterone deficiency.
- Veedma uses decision thresholds of 350 ng/dL for total testosterone and 100 pg/mL for free testosterone when symptoms persist.
- LH and FSH must be measured with testosterone because high LH plus low testosterone suggests primary hypogonadism, while low or normal LH plus low testosterone suggests secondary hypogonadism.
- Proper testing is done in the morning, from 07:00 to 11:00, with total testosterone by LC-MS/MS and free testosterone measured directly by equilibrium dialysis with LC-MS/MS.
- In healthy aging men, testosterone declines slowly. EMAS reported about a 0.4% yearly fall in total testosterone and a 1.3% yearly fall in free testosterone.
- Symptomatic hypogonadism in men ages 40 to 79 has been reported in roughly 2.1% to 5.7% of men, depending on the study and the diagnostic criteria used.
- TRT suppresses gonadotropins and sperm production, while Enclomiphene can preserve fertility and is the preferred first line treatment for secondary and functional hypogonadism when LH is below 8 mIU/mL.
Overview and stats
Low testosterone means symptomatic male hypogonadism, not just a lab value that falls near the bottom of a reference range. The best place to start is What is low testosterone? The clinical definition most men (and many doctors) get wrong, which explains why symptoms and biochemistry both matter. For age based context, see Low testosterone by age: What’s normal at 20, 30, 40, 50, and beyond. That article separates normal aging from disease and explains why a sharp drop is usually driven by obesity, metabolic disease, medications, or other health problems rather than age alone.
Prevalence is meaningful, but it changes with the definition used. According to the EAU male hypogonadism guideline, symptomatic hypogonadism in men ages 40 to 79 has been reported in the low single digits, and longitudinal EMAS data suggest that healthy aging is associated with only a small yearly decline in testosterone. For population context and why more younger men are being evaluated, read How common is low testosterone, and why are rates rising in younger men?.
Causes and how it develops
Where low testosterone starts determines treatment. If LH is high and testosterone is low, the testes are failing to respond and the pattern is primary hypogonadism. If LH is low or normal and testosterone is low, the problem is central, which points to secondary hypogonadism and often opens the door to fertility preserving treatment. The core primer here is Primary vs secondary hypogonadism: where the problem starts and why it changes everything. It shows why two men with the same testosterone result may need completely different care.
The biology makes more sense once you understand the signaling loop. How the HPG axis works: the brain testes connection explained walks through GnRH, LH, FSH, testicular testosterone production, and feedback regulation. According to the Endocrine Society guideline, medications, systemic illness, and obesity can suppress the axis and create a functional or secondary pattern. For the practical causes men miss most often, including opioids and lifestyle factors, read Medications, substances, and lifestyle factors that quietly kill your testosterone.
Signs and symptoms
The most specific symptom pattern is the sexual triad of reduced libido, erectile dysfunction, and loss of spontaneous or morning erections. Those symptoms are far more useful diagnostically than vague complaints alone. For a full symptom map, read Low testosterone symptoms: the complete list most men don’t recognize. It separates sexual symptoms, which are the most specific, from physical symptoms such as lower activity tolerance and decreased mobility, and from psychological symptoms such as low motivation, fatigue, and low mood.
Age of onset changes presentation. According to the EMAS study published in The New England Journal of Medicine, the combination of sexual symptoms and low testosterone improves diagnostic specificity in adult men. But symptoms in a man in his twenties may look different from symptoms in a man in his sixties, and congenital or pubertal onset has a very different clinical picture. How low testosterone symptoms show up differently at every age explains those differences and why the same diagnosis does not look the same across the lifespan.
Testing and diagnosis
Diagnosis starts with symptoms and a properly timed morning panel from 07:00 to 11:00 that includes total testosterone, free testosterone, LH, and FSH. If testosterone is low or borderline, repeat morning testing is usually needed to confirm hypogonadism before treatment decisions are made. For the full protocol, read The complete low testosterone testing guide: what to order, when to test, and how to read results. It covers when not to test, why acute illness can temporarily lower testosterone, and why obesity, diabetes, medications, and treatment contraindications should be reviewed before results are interpreted.
Testing quality matters as much as the number itself. According to the EAU guideline, diagnosis should rely on reliable morning testing, and the Endocrine Society also emphasizes confirmation and careful evaluation. Why your testosterone test came back “normal” and why that might be wrong explains common failures, including broad lab ranges, afternoon testing, and hidden deficiency in men with high SHBG. Veedma prioritizes free testosterone measured directly by equilibrium dialysis with LC-MS/MS, rather than calculated estimates, and always measures LH and FSH alongside testosterone.
Related conditions
Obesity, metabolic syndrome, and type 2 diabetes are among the strongest clinical contexts for low testosterone. These conditions do not just coexist with hypogonadism. They can help drive it, and low testosterone can then worsen body composition, insulin resistance, and physical function. Obesity, metabolic syndrome, and type 2 diabetes: the low testosterone triangle explains this self reinforcing loop and why visceral fat is especially relevant. It is one of the most important articles in this cluster because functional hypogonadism is the most common real world form seen in practice.
Low testosterone is also linked to mood symptoms, lower quality of life, and bone health concerns, although association is not the same as proof of cause. According to the EAU guideline, depressive symptoms and reduced quality of life are commonly reported in hypogonadal men, but the relationship is complex. Depression, bone loss, and other conditions linked to low testosterone covers what is established, what remains uncertain, and why testosterone therapy should not be framed as a treatment for type 2 diabetes itself.
Similar conditions to exclude
Symptoms like fatigue, low mood, weight change, poor concentration, and sexual dysfunction can come from many conditions besides hypogonadism. That is why low testosterone is a diagnosis of inclusion and exclusion. It might not be low testosterone: conditions that mimic the same symptoms reviews the overlap with thyroid disorders, depression, anxiety, sleep problems, medication effects, and other causes of low energy or sexual symptoms. In real practice, those lookalikes are one reason a simple “your testosterone is normal” or “your testosterone is low” approach often fails men.
Functional hypogonadism deserves special attention because it is common, potentially reversible, and easy to misclassify. According to the EAU guideline, obesity and chronic disease can suppress an otherwise intact axis, which means the testes may still respond if signaling is restored. Functional vs organic hypogonadism: is your low T reversible? explains how clinicians distinguish structural disease from reversible suppression and why that distinction changes prognosis, fertility planning, and treatment choice.
Treatment options
Treatment should follow the diagnosis. Enclomiphene is the preferred first line option for secondary and functional hypogonadism when LH is below 8 mIU/mL, while testosterone replacement therapy is reserved for primary hypogonadism or for secondary cases that do not respond to Enclomiphene. Alternatives to TRT: Enclomiphene, hCG, lifestyle, and fertility preserving options explains why this matters. Enclomiphene works by blocking estrogen feedback at the hypothalamus, increasing GnRH and LH, and stimulating the testes to make testosterone naturally. That means it can preserve spermatogenesis and testicular function instead of suppressing them.
TRT still has an important medical role, but it is not the right first step for every man. Testosterone replacement therapy: formulations, dosing, and what to expect covers the major formulations and what men should understand before starting. According to the TRAVERSE trial, TRT was noninferior to placebo for major cardiovascular events in 5,246 men followed for a mean of 33 months, but hematocrit elevation remained the most common adverse effect to monitor. Veedma does not prescribe TRT or testosterone injections. Its medical team focuses on thorough diagnosis, Enclomiphene as first line care when appropriate, and the Enclomiphene plus Tadalafil combination tablet when erection or urinary symptoms are also part of the picture.
Recovery and outlook
Hormone levels can begin changing within weeks, but symptom improvement usually unfolds over 4 to 12 weeks and body composition changes take longer. What to expect after starting treatment: realistic timelines and monitoring sets realistic expectations for sexual symptoms, mood, energy, and physical changes. It also explains why lab follow up is not optional. Veedma’s approach is to repeat labs after the first month of treatment and then every 6 months, using the same core framework of total testosterone, free testosterone, LH, FSH, estradiol, CBC, Comprehensive Metabolic Panel, vitamin D, and PSA for men age 40 and older.
Long term outlook depends on the type of hypogonadism and whether the driver is reversible. Living with low testosterone: long term management and outcomes focuses on what happens after the initial response, including how comorbidities, medication changes, weight trends, and fertility plans influence treatment length. According to the Endocrine Society, therapy should target men with documented hypogonadism rather than “optimization” or anti aging use. In functional hypogonadism, ongoing reassessment matters because some men can eventually reduce or stop treatment once the underlying suppression improves.
Frequently asked questions
- What actually counts as low testosterone?
- Low testosterone means symptomatic male hypogonadism. In practice, that requires persistent symptoms plus biochemical evidence of deficiency on proper testing. At Veedma, the working decision thresholds are total testosterone below 350 ng/dL or free testosterone below 100 pg/mL when symptoms persist.
- Is low testosterone just a normal part of getting older?
- No. Healthy aging is associated with a relatively small yearly decline in testosterone, not a sudden collapse. When levels fall more sharply, clinicians should look for obesity, type 2 diabetes, medication effects, sleep problems, chronic disease, or another cause of functional or organic hypogonadism.
- Why do LH and FSH matter so much?
- LH and FSH show where the problem starts. High LH with low testosterone points to primary hypogonadism, where the testes are not responding well. Low or normal LH with low testosterone points to secondary hypogonadism, where the brain is not sending a strong enough signal, and that distinction directly changes treatment and fertility implications.
- Can you have low testosterone symptoms even if your lab report says “normal”?
- Yes. A “normal” result may be misleading if the sample was drawn in the afternoon, if only total testosterone was checked, or if free testosterone was not measured accurately. Broad reference ranges can also hide clinically meaningful deficiency in younger or symptomatic men.
- Is functional hypogonadism reversible?
- Often, yes. Functional hypogonadism means the HPG axis is suppressed rather than structurally damaged, usually by obesity, metabolic disease, medications, or systemic illness. Some men improve when those drivers are treated, and Enclomiphene can help restore natural testosterone production while the underlying issues are addressed.
- Will testosterone replacement therapy affect fertility?
- Yes. TRT suppresses gonadotropins and can reduce or stop sperm production, which is why it is a poor fit for men who want to preserve fertility. That is one reason Enclomiphene is so important in secondary and functional hypogonadism, because it can raise testosterone while keeping the axis active.
- How long does it take to feel better after treatment starts?
- Lab changes can appear early, but symptom relief is usually not immediate. Men may notice sexual or energy improvements within several weeks to a few months, while body composition and longer term physical changes usually take more time. Follow up testing is essential so treatment can be adjusted based on both symptoms and objective results.
What to do about it
If you think low testosterone may be part of the picture, the next step is not to guess. It is to get the right workup. Veedma’s licensed providers can review existing labs, including uploads from services like Function Health, or order a men’s health panel across the U.S. that includes total testosterone by LC-MS/MS, free testosterone by equilibrium dialysis with LC-MS/MS, LH, FSH, estradiol, CBC, Comprehensive Metabolic Panel, vitamin D, PSA for men age 40 and older, insulin when BMI is above 25, and additional tests when clinically indicated. From there, the medical team builds an individualized plan, usually with Enclomiphene as first line care for secondary or functional hypogonadism, or the Enclomiphene plus Tadalafil combination tablet when erection or urinary symptoms are also present. Start with a diagnostic review so treatment matches the biology.
How we write and review this content
This hub is developed by Veedma’s editorial team using AI assisted research tools, then reviewed for medical accuracy by Vladimir Kotlov, MD, urologist and founder of Veedma. The evidence base for this page includes guidance from the EAU, AUA, and Endocrine Society, observational data from EMAS, and relevant randomized trials such as TRAVERSE. Our goal is to separate diagnosis from hype so men can understand what low testosterone is, what it is not, and how a proper evaluation should work.
This content is educational and does not diagnose or treat any individual. It is designed to help readers understand testing, symptoms, causes, and treatment pathways so they can have better conversations with licensed providers. Read our full editorial policy.
Get your FREE testosterone guide
Any treatment is a big decision. Get the facts first. Our Testosterone 101 guide helps you decide if treatment is right for you.

Vladimir Kotlov, MD: Founder & CEO at Veedma
Vladimir Kotlov, MD is the founder of Veedma. A urologist by training, he led a urology department at a fertility and reproductive clinic where he managed a team of 30+ clinicians and improved IVF outcomes by 24%. He then moved to Silicon Valley and spent five years advising healthtech companies before founding Veedma to help men access evidence-based hormone optimization and fertility care.